Efficacy of allergen-specific immunotherapy for patients with atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 4, 2013, Pages 1012-1013

  Tam, Herman ^a   Calderon, Moises A ^b   Boyle, Robert J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN SPECIFIC IMMUNOTHERAPY; ATOPIC DERMATITIS; DISEASE SEVERITY; ECZEMA; IMMUNOTHERAPY; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); THERAPY EFFECT;

DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS;

EID: 84884908115     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.07.021     Document Type: Letter

References (12)

1. J.M. Bae, Y.Y. Choi, C.O. Park, K.Y. Chung, and K.H. Lee Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials J Allergy Clin Immunol 132 2013 110 117
2. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 W64
3. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed June 13, 2013.
4. B.P. Leroy, G. Boden, J.M. Lachapelle, M.G. Jacquemin, and J.M. Saint-Remy A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study J Am Acad Dermatol 28 1993 232 239
5. G.B. Pajno, L. Caminiti, D. Vita, G. Barberio, G. Salzano, and F. Lombardo Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study J Allergy Clin Immunol 120 2007 164 170
6. H.S. Kaufman, and H.L. Roth Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study Ann Allergy 32 1974 321 330
7. M.T. Glover, and D.J. Atherton A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema Clin Exp Allergy 22 1992 440 446
8. C. Charman, C. Chambers, and H. Williams Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 120 2003 932 941
9. J.O. Warner, J.F. Price, J.F. Soothill, and E.N. Hey Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma Lancet 2 1978 912 915
10. E. Galli, L. Chini, S. Nardi, N. Benincori, P. Panei, and G. Fraioli Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis Allergol Immunopathol (Madr) 22 1994 18 22
11. W. Silny, and M. Czarnecka-Operacz Specific immunotherapy in the treatment of patients with atopic dermatitis - results of a double-blind, placebo-controlled study Allergologie 29 2006 171 183
12. N. Novak, T. Bieber, M. Hoffmann, R. Folster-Holst, B. Homey, and T. Werfel Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis J Allergy Clin Immunol 130 2012 925 931